Puration, Inc (OTCMKTS:PURA) announced recently during the previous event in March at the Arnold Sports Festival, in Columbus, Ohio that it’s launching a new campaign for its products on Instagram and will feature the pics of popular icon athletes and fans holding the product.
The firm’s EVERx CBD Infused Sports Water is developed using two patents that are combined to produce exceptional products suitable for beverage industry. The product also has components of CBD infusions including the antioxidants and electrolytes that are beneficial to the user.
At the festival Puration’s new Kiwi-Strawberry and Lemmon-Lime flavored EVERx CBD Infused Sports Waters were a hit with athletes and fans. The products have optimal alkaline pH level that is effective in reducing hydration among the users in the alkaline water markets. The company anticipates generating more revenue from the event.
Cee Jay Hamilton, a popular and dynamic fighter was featured in the recent Annual Arnold Sports Festival event when Puration was launching its two products where he displayed the EVERx logo on his entire outfit. Hamilton commented that he is working to become the world’s sports champion and supporting PURA’s endeavours gives him pleasure and strength to work effectively. He intends to go a notch higher now that he’s charged by EVERx. Stand by and be on the lookout for there Instagram ads and campaign.
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio OregonEditor - November 27, 2018
Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma AcquisitionEditor - November 26, 2018
Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical TrialsEditor - November 26, 2018
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…